![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Pfizer Testing Abuse-Deterrent Compound of Oxycodone and Naltrexone
Pfizer Testing Abuse-Deterrent Compound of Oxycodone and Naltrexone
September 10, 2013
Pfizer is currently in Phase III trials testing a combination of oxycodone and naltrexone that it claims relieves pain without being addictive.
Pain Medicine News
Pain Medicine News
Upcoming Events
-
21Oct